Quantcast

Latest venture capital Stories

2014-10-30 08:34:48

More work needed to continue upward trajectory INDIANAPOLIS, Oct. 30, 2014 /PRNewswire/ -- A new report, commissioned by BioCrossroads and conducted by the Battelle Technology Partnership Practice, takes an in-depth look at Indiana's capital market and the innovation outputs that have resulted over two different time frames: 1993 to 2002 and 2003 to 2013. It also provides a view of future opportunities for investment growth. The Life Science Innovation Capital in Indiana report shows gains...

2014-10-29 23:07:18

Strategic Capital Partners, LLC delivered its first in a planned series of angel investment events bringing together the region’s emerging-growth technology companies with private equity investors. Frederick, MD (PRWEB) October 29, 2014 Strategic Capital Partners, LLC delivered its first in a planned series of angel investment events bringing together the region’s emerging-growth technology companies with private equity investors. The October 8 event held at Dutch’s Daughter...

2014-10-29 23:02:15

Texas private equity firm, Teakwood Capital adds Bob Mosteller to its team. Bob brings deep financial, investment and operational expertise to the firm and its portfolio companies. Dallas, TX (PRWEB) October 29, 2014 Teakwood Capital, a Dallas, Texas private equity firm welcomes Bob Mosteller as Managing Director of Finance and Chief Financial Officer. Bob brings over two decades of experience in finance and operations across a diverse set of industries. As CFO, he will oversee the...

2014-10-29 16:28:16

-- Financing Provided by New Investors Apple Tree Partners, BioStar Ventures, Windham Venture Partners and a Strategic Investor Alongside Existing Investors SUNNYVALE, Calif., Oct. 29, 2014 /PRNewswire/ -- VytronUS, Inc. ("VytronUS"), a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias, announced today that it has secured $31.6 million in an oversubscribed Series B financing. The round was led by Apple Tree Partners,...

2014-10-29 08:40:13

Peraso Poised for Leadership Position in WiGig® IC Sales TORONTO, Oct. 29, 2014 /CNW/ - Peraso Technologies Inc., a leader in Wireless Gigabit (WiGig®) chipsets, announced today that it has closed a $20 million funding round. The oversubscribed round was led by new investor Roadmap Capital, with additional financing from existing investors Celtic House Venture Partners, Ontario Emerging Technologies Fund (OETF) and VentureLink Funds. Peraso is a provider of low cost, low power...

2014-10-29 08:39:20

Funds to accelerate dynamic growth SAN FRANCISCO, Oct. 29, 2014 /PRNewswire/ -- Personal Capital, a leading digital wealth management firm, has completed a $50 million capital raise for its Series D financing. The funding was led by Corsair Capital, a highly regarded private equity firm focused on financial services, as well as BBVA Ventures and USAA. Personal Capital's existing venture investors - IVP, Venrock and Crosslink - also participated in the round. "We're leading the...

2014-10-28 23:04:47

Bullpen Capital, Vator and Venture 51 host event to address critical funding gap between seed and Series A round investment San Francisco, CA (PRWEB) October 28, 2014 Khosla Ventures’ Keith Rabois, Andreessen Horowitz’s Chris Dixon and AngelList founder Naval Ravikant will be the keynote speakers at the Post Seed Conference, a one-day event that gathers investors, entrepreneurs and the startup press to discuss early-stage financing. Hosted by Bullpen Capital, Venture51 and Vator, Post...

2014-10-28 16:27:32

Another Big Win for BIP Capital in Workflow Solutions ATLANTA, Oct. 28, 2014 /PRNewswire/ -- BIP Capital announces the sale if its interest in Ingenious Med to North Bridge Growth Equity, a Boston-based private equity firm. The sale generated a 9x gross return for BIP Capital and its first round investors. "Ingenious Med represents everything BIP Capital looks for in an investment - large market opportunity, an industry leading product, and accelerating revenues," said Mark...

2014-10-28 08:37:00

CLEVELAND, Oct. 28, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease announced today that Troy Ignelzi has joined the company as Senior Vice President of Finance and Operations. Troy brings 20 years in finance, operations, and business development experience with start-up and established life sciences companies....

2014-10-28 04:22:34

LONDON, October 28, 2014 /PRNewswire/ -- Advent Life Sciences today announced the closing of Advent Life Sciences Fund II (ALSF II), a GBP145.5M (USD 235M) venture capital fund raised to seed and build life sciences companies in the UK, Europe and the US. The Fund will back entrepreneurs and early-stage and mid-stage companies with the potential to deliver first- or best-in-class breakthrough products for unmet medical needs. The Fund, which quickly exceeded its target, was...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.